Vascular aging in women: Is estrogen the fountain of youth?

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Novella, Susana ^a,b   Dantas, Ana Paula ^c   Segarra, Gloria ^a,b   Medina, Pascual ^a,b   Hermenegildo, Carlos ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Endothelium; Estradiol; Menopause; Nitric oxide; Vascular protection

Indexed keywords

EID: 84866405855     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00165     Document Type: Article

References (121)

1. Alexander, S. P., Mathie, A., and Peters, J. A. (2008). Guide to receptors and channels (GRAC), 3rd edition. Br. J. Pharmacol. 153(Suppl. 2), S1-S209.
2. Arnal, J. F., Clamens, S., Pechet, C., Negre-Salvayre, A., Allera, C., Giro-lami, J. P., Salvayre, R., and Bayard, F. (1996). Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothe-lial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. U.S.A. 93, 4108-4113.
3. Avolio, A. P., Chen, S. G., Wang, R. P., Zhang, C.L., Li, M.F., and O'Rourke, M. F. (1983). Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 68, 50-58.
4. Bairey Merz, C. N., Shaw, L. J., Reis, S. E., Bittner, V., Kelsey, S. F., Olson, M., Johnson, B. D., Pepine, C. J., Mankad, S., Sharaf, B. L., Rogers, W. J., Pohost, G. M., Lerman, A., Quyyumi, A. A., and Sopko, G. (2006). Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based patho-physiology of atherosclerosis and macrovascular and microvascular coronary disease. J. Am. Coll. Cardiol. 47, S21-S29.
5. Barton, M. (2010). Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch. 460, 825-837.
6. Beato, M., Herrlich, P., and Schutz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83,851-857.
7. Briones, A. M., Montoya, N., Giraldo, J., and Vila, E. (2005). Ageing affects nitric oxide synthase, cyclooxyge-nase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton. Autacoid Pharmacol. 25, 155-162.
8. Brosnihan, K. B., Senanayake, P. S., Li, P., and Ferrario, C. M. (1999). Bi-directional actions of estrogen on the renin-angiotensin system. Braz. J. Med. Biol. Res. 32, 373-381.
9. Cano, A., andHermenegildo, C. (2000). Modulation of the oestrogen receptor: a process with distinct susceptible steps. Hum. Reprod. Update 6, 207-211.
10. Capel, I. D., Jenner, M., Williams, D. C., Donaldson, D., and Nath, A. (1981). The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. J. Steroid Biochem. 14, 729-732.
11. Crews, J. K., and Khalil, R. A. (1999). Antagonistic effects of 17b-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler. Thromb. Vasc. Biol. 19, 1034-1040.
12. Dantas, A. P., Scivoletto, R., Fortes, Z. B., Nigro, D., and Carvalho, M. H. (1999). Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. Hypertension 34,914-919.
13. Dantas, A. P., Tostes, R. C., Fortes, Z. B., Costa, S. G., Nigro, D., and Carvalho, M. H. (2002). In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 39, 405-411.
14. David, F. L., Carvalho, M. H., Cobra, A. L., Nigro, D., Fortes, Z. B., Reboucas, N. A., and Tostes, R. C. (2001). Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 38, 692-696.
15. Davidge, S. T., and Zhang, Y. (1998). Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ. Res. 83, 388-395.
16. Deschamps, A. M., and Murphy, E. (2009). Activation of a novel estrogen receptor, GPER, is cardioprotec-tive in male and female rats. Am. I Physiol. Heart Circ. Physiol. 297, H1806-H1813.
17. Dubey, R. K., and Jackson, E. K. (2001). Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol Renal Physiol. 280, F365-F388.
18. Dudzinski, D. M., and Michel, T. (2007). Life history of eNOS: partners and pathways. Cardiovasc. Res. 75,247-260.
19. Eaker, E. D., Chesebro, J. H., Sacks, F. M., Wenger, N. K., Whisnant, J. P., and Winston, M. (1993). Cardiovascular disease in women. Circulation 88,1999-2009.
20. Erdely, A., Greenfeld, Z., Wagner, L., and Baylis, C. (2003). Sexual dimorphism in the aging kidney: effects on injury and nitric oxide system. Kidney Int. 63,1021-1026.
21. Erusalimsky, J. D. (2009). Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 106, 326-332.
22. Eskurza, I., Myerburgh, L. A., Kahn, Z. D., and Seals, D. R. (2005). Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J. Physiol. 568, 1057-1065.
23. Freay, A. D., Curtis, S. W., Korach, K. S., and Rubanyi, G. M. (1997). Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta. Role of nuclear estrogen receptor and Ca uptake. Circ. Res. 81,242-248.
24. Frink, R. J. (2009). Gender gap, inflammation and acute coronary disease: are women resistant to atheroma growth? Observations at autopsy. J. Invasive Cardiol. 21,270-277.
25. Gambacciani, M., Rosano, G. M., Monteleone, P., Fini, M., and Genazzani, A. R. (2002). Clinical relevance of the HERS trial. Lancet 360, 641.
26. Giannattasio, C., Failla, M., Grappiolo, A., Stella, M. L., Del, B. A., Colombo, M., and Mancia, G. (1999). Fluctuations of radial artery distensibility throughout the menstrual cycle. Arterioscler. Thromb. Vasc. Biol. 19, 1925-1929.
27. Golding, E. M., and Kepler, T. E. (2001). Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. Am. J. Physiol. Heart Circ. Physiol. 280, H2417-H2423.
28. Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W C, Speizer, F. E., and Stampfer, M. J. (2000). A prospective, observational study of post-menopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133, 933-941.
29. Grodstein, F., Manson, J. E., and Stampfer, M. J. (2001). Post-menopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Ann. Intern. Med. 135,1-8.
30. Grodstein, F., Manson, J. E., and Stampfer, M. J. (2006). Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J. Womens Health (Larchmt.) 15, 35-44.
31. Haas, E., Meyer, M. R., Schurr, U., Bhattacharya, I., Minotti, R., Nguyen, H. H., Heigl, A., Lachat, M., Genoni, M., and Barton, M. (2007). Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49,1358-1363.
32. Halliwell, B., and Grootveld, M. (1987). The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213, 9-14.
33. Han, S. Z., Karaki, H., Ouchi, Y., Akishita, M., and Orimo, H. (1995). 17b-Estradiol inhibits Ca influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 91, 2619-2626.
34. Harman, S. M. (2004). What do hormones have to do with aging? What does aging have to do with hormones? Ann. N. Y. Acad. Sci. 1019, 299-308.
35. Harman, S. M. (2006). Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend. Med. 3, 254-269.
36. Hayashi, T., Yano, K., Matsui-Hirai, H., Yokoo, H., Hattori, Y., and Iguchi, A. (2008). Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 120,333-339.
37. Hermenegildo, C., Garcia-Martinez, M. C., Tarin, J. J., and Cano, A. (2002). Inhibition of low-density lipopro-tein oxidation by the pure antiestro-gens ICI 182780 and EM-652 (SCH 57068). Menopause 9, 430-435.
38. Herrera, M. D., Mingorance, C., Rodriguez-Rodriguez, R., and Alvarez de Sotomayor, M. (2010). Endothelial dysfunction and aging: an update. Ageing Res. Rev. 9, 142-152.
39. Hisamoto, K., Ohmichi, M., Kurachi, H., Hayakawa, J., Kanda, Y., Nishio, Y., Adachi, K., Tasaka, K., Miyoshi, E., Fujiwara, N., Taniguchi, N., and Murata, Y. (2001). Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 276, 3459-3467.
40. Huang, A., Sun, D., Kaley, G., and Koller, A. (1997). Estrogen maintains nitric oxide synthesis in arte-rioles of female hypertensive rats. Hypertension 29, 1351-1356.
41. Jacobson, A., Yan, C., Gao, Q., Rincon-Skinner, T., Rivera, A., Edwards, J., Huang, A., Kaley, G., and Sun, D. (2007). Aging enhances pressure-induced arterial superoxide formation. Am. J. Physiol. Heart Circ. Physiol. 293, H1344-H1350.
42. Johnson, B. D., Zheng, W., Korach, K. S., Scheuer, T., Catterall, W A., and Rubanyi, G. M. (1997). Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J. Gen. Physiol. 110, 135-140.
43. Karas, R. H., Patterson, B. L., and Mendelsohn, M. E. (1994). Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89,1943-1950.
44. Kielstein, J. T., Bode-Boger, S. M., Frolich, J. C., Ritz, E., Haller, H., and Fliser, D. (2003). Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107,1891-1895.
45. Kim, J., Kim, J. Y., Song, K. S., Lee, Y H., Seo, J. S., Jelinek, J., Goldschmidt-Clermont, P. J., and Issa, J. P. (2007). Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 1772, 72-80.
46. Kim, J. H., Bugaj, L. J., Oh, Y. J., Bivalac-qua, T. J., Ryoo, S., Soucy, K. G., Santhanam, L., Webb, A., Camara, A., Sikka, G., Nyhan, D., Shoukas, A. A., Ilies, M., Christianson, D. W., Champion, H. C., and Berkowitz, D. E. (2009). Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 107, 1249-1257.
47. Kim, Y D., Chen, B., Beauregard, J., Kouretas, P., Thomas, G., Farhat, M. Y., Myers, A. K., and Lees, D. E. (1996). 17b-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 94,2901-2908.
48. Kim-Schulze, S., McGowan, K. A., Hubchak, S. C., Cid, M. C., Martin, M. B., Kleinman, H. K., Greene, G. L., andSchnaper, H. W (1996). Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94, 1402-1407.
49. Kitazawa, T., Hamada, E., Kitazawa, K., and Gaznabi, A. K. (1997). Non-genomic mechanism of 17b-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J. Physiol. 499, 497-511.
50. Kovacic, J. C., Moreno, P., Nabel, E. G., Hachinski, V., and Fuster, V. (2011). Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation 123, 1900-1910.
51. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93,5925-5930.
52. Lakatta, E. G., and Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 107, 139-146.
53. Lamas, S., Lowenstein, C. J., and Michel, T. (2007). Nitric oxide signaling comes of age: 20 years and thriving. Cardiovasc. Res. 75,207-209.
54. LeBlanc, A. J., Reyes, R., Kang, L. S., Dailey, R. A., Stallone, J. N., Moningka, N. C., and Muller-Delp, J. M. (2009). Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1713-R1723.
55. Lekontseva, O. N., Rueda-Clausen, C. R, Morton, J. S., and Davidge, S. T. (2010). Ovariectomy in aged versus young rats augments matrix metalloproteinase-mediated vasoconstriction in mesenteric arteries. Menopause 17, 516-523.
56. Lerner, D. J., and Kannel, W. B. (1986). Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framing-ham population. Am. Heart J. 111, 383-390.
57. Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B B., Hunt, J. R., Ludlam, S. E., Pettinger, M. B., Gass, M., Margolis, K. L., Nathan, L., Ockene, J. K., Prentice, R. L., Robbins, J., and Stefanick, M. L. (2007). Estro gen therapy and coronary-artery cal cification. N. Engl J. Med. 356, 2591-2602.
58. Messerli, F. H., Garavaglia, G. E., Schmieder, R. E., Sundgaard-Riise, K., Nunez, B. D., and Amodeo, C (1987). Disparate cardiovascular findings in men and women with essential hypertension. Ann. Intern. Med. 107, 158-161.
59. Meyer, M. R., Prossnitz, E. R., and Barton, M. (2011). The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul. Pharmacol. 55, 17-25.
60. Michel, T., and Vanhoutte, P. M. (2010). Cellular signaling and NO production. Pflugers Arch. 459, 807-816.
61. Miller, V. M., and Duckles, S. P. (2008). Vascular actions of estrogens: functional implications. Pharmacol. Rev. 60,210-241.
62. Monsalve, E., Oviedo, P. J., Garcia-Perez, M. A., Tarin, J. J., Cano, A., and Hermenegildo, C. (2007). Estradiol counteracts oxidized LDL-induced asymmetric dimethylargi-nine production by cultured human endothelial cells. Cardiovasc. Res. 73, 66-72.
63. Moreau, K. L., Donato, A. J., Seals, D. R., DeSouza, C. A., and Tanaka, H. (2003). Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women. Cardiovasc. Res. 57, 861-868.
64. Moreau, K. L., Meditz, A., Deane, K., and Kohrt, W. M. (2012). Tetrahy-drobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Am. J. Physiol Heart Circ. Physiol. 302, H1211-H1218.
65. Murphy, E. (2011). Estrogen signaling and cardiovascular disease. Circ. Res. 109, 687-696.
66. Murphy, J. G., and Khalil, R. A. (1999). Decreased [Ca2+]i during inhibition of coronary smo oth muscle contraction by 17b-estradiol, progesterone, and testosterone. J. Pharmacol. Exp. Ther. 291, 44-52.
67. Nakajima, T., Kitazawa, T., Hamada, E., Hazama, H., Omata, M., and Kurachi, Y. (1995). 17b-Estradiol inhibits the voltage-dependent L-type Ca currents in aortic smooth muscle cells. Eur. J. Pharmacol. 294, 625-635.
68. Novella, S., Dantas, A. P., Segarra, G., Novensa, L., Bueno, C., Heras, M., Hermenegildo, C., and Medina, P. (2010). Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Exp. Gerontol. 45, 868-874.
69. Novella, S., Dantas, A. P., Segarra, G., Novensa, L., Heras, M., Hermenegildo, C., and Medina, P. (2011). Aging enhances contraction to thromboxane A(2) in aorta from female senescence-accelerated mice. Age (Dordr.). (in press).
70. Novensa, L., Novella, S., Medina, P., Segarra, G., Castillo, N., Heras, M., Hermenegildo, C., and Dantas, A. P. (2011). Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERalpha/ERbeta balance in female mice. PLoS ONE 6, e25335. doi:10.1371/journal.pone.0025335
71. Ospina, J. A., Krause, D. N., and Duckles, S. P. (2002). 17b-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33, 600-605.
72. Pechenino, A. S., Lin, L., Mbai, F. N., Lee, A. R., He, X. M., Stallone, J. N., and Knowlton, A. A. (2011). Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol. Genomics 43, 1065-1073.
73. Pereira, T. M., Nogueira, B. V., Lima, L. C., Porto, M. L., Arruda, J. A., Vasquez, E. C., and Meyrelles, S. S. (2010). Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis. 9, 87.
74. Post, W. S., Goldschmidt-Clermont, P. J., Wilhide, C. C., Heldman, A. W., Sussman, M. S., Ouyang, P., Milliken, E. E., and Issa, J. P. (1999). Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43,985-991.
75. Prakash, Y. S., Togaibayeva, A. A., Kannan, M. S., Miller, V. M., Fitzpatrick, L. A., and Sieck, G. C. (1999). Estrogen increases Ca2+ efflux from female porcine coronary arterial smooth muscle. Am. J. Physiol. 276, H926-H934.
76. Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M., Jackson, R. D., Johnson, K. C., Kuller, L. H., Lane, D. S., Wactawski-Wende, J., Brzyski, R., Allison, M., Ockene, J., Sarto, G., and Rossouw, J. E. (2009). Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am. J. Epidemiol. 170, 12-23.
77. Price, J. M., Hellermann, A., Hellermann, G., and Sutton, E. T. (2004). Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid. Neurol. Res. 26, 305-311.
78. Prossnitz, E. R., and Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 7, 715-726.
79. Register, T. C., and Adams, M. R. (1998). Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J. Steroid Biochem. Mol. Biol. 64, 187-191.
80. Robb, E. L., and Stuart, J. A. (2011). Resveratrol interacts with estrogen receptor-beta to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondr-ial superoxide dismutase. Free Radic. Biol. Med. 50, 821-831.
81. Rodriguez-Manas, L., El-Assar, M., Vallejo, S., Lopez-Doriga, P., Solis, J., Petidier, R., Montes, M., Nevado, J., Castro, M., Gomez-Guerrero, C., Peiro, C., and Sanchez-Ferrer, C. F. (2009). Endothelial dysfunction in aged humans is related with oxida-tive stress and vascular inflammation. Aging Cell 8,226-238.
82. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de, S. G., Ford, E. S., Fox, C. S., Fullerton, H. J., Gillespie, C., Greenlund, K. J., Hailpern, S. M., Heit, J. A., Ho, P. M., Howard, V. J., Kissela, B. M., Kit-tner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Makuc, D. M., Marcus, G. M., Marelli, A., Matchar, D. B., McDermott, M. M., Meigs, J. B., Moy, C. S., Mozaffarian, D., Mussolino, M. E., Nichol, G., Paynter, N. P., Rosamond, W. D., Sorlie, P. D., Stafford, R. S., Turan, T. N., Turner, M. B., Wong, N. D., and Wylie-Rosett, J. (2011). Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123, e18-e209.
83. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O'Donnell, C., Roger, V., Sorlie, P., Steinberger, J., Thom, T., Wilson, M., and Hong, Y. (2008). Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146.
84. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., and Ockene, J. (2002). Risks and benefits of estrogen plus prog-estin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288, 321-333.
85. Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., and Stefanick, M. L. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297, 1465-1477.
86. Rubio-Gayosso, I., Sierra-Ramirez, A., Garcia-Vazquez, A., Martinez-Martinez, A., Munoz-Garcia, O., Morato, T., and Ceballos-Reyes, G. (2000). 17b-estradiol increases intracellular calcium concentration through a short-term and nongenomic mechanism in rat vascular endothelium in culture. J. Cardiovasc. Pharmacol. 36,196-202.
87. Santhanam, L., Christianson, D. W., Nyhan, D., and Berkowitz, D. E. (2008). Arginase and vascular aging. J. Appl Physiol. 105, 1632-1642.
88. Schmidt, R. J., Beierwaltes, W. H., and Baylis, C. (2001). Effects of aging and alterations in dietary sodium intake on total nitric oxide production. Am. J. Kidney Dis. 37, 900-908.
89. Seals, D. R., Jablonski, K. L., and Donato, A. J. (2011). Aging and vascular endothelial function in humans. Clin. Sci. 120, 357-375.
90. Seely, E. W., Brosnihan, K. B., Jeunemaitre, X., Okamura, K., Williams, G. H., Hollenberg, N. K., and Herrington, D. M. (2004). Effects of conjugated oestrogen and droloxifene on the reninangiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin. Endocrinol. (Oxf.) 60, 315-321.
91. Shaw, L. J., Bairey Merz, C. N., Pepine, C. J., Reis, S. E., Bittner, V., Kelsey, S. F., Olson, M., Johnson, B. D., Mankad, S., Sharaf, B. L., Rogers, W. J., Wessel, T. R., Arant, C. B., Pohost, G. M., Lerman, A., Quyyumi, A. A., and Sopko, G. (2006). Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J. Am. Coll. Cardiol. 47, S4-S20.
92. Sherwood, A., Bower, J. K., McFetridge-Durdle, J., Blumenthal, J. A., Newby, L. K., and Hinderliter, A. L. (2007). Age moderates the short-term effects of transdermal 17b-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 27, 1782-1787.
93. Shi, Y., Man, R. Y., and Vanhoutte, P. M. (2008). Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year-old rats. Acta Pharmacol. Sin. 29,185-192.
94. Silva-Antonialli, M. M., Fortes, Z. B., Carvalho, M. H., Scivoletto, R., and Nigro, D. (2000). Sexual dimorphism in the response of thoracic aorta from SHRs to losartan. Gen. Pharmacol. 34, 329-335.
95. Sivritas, D., Becher, M. U., Ebrahimian, T., Arfa, O., Rapp, S., Bohner, A., Mueller, C. F., Umemura, T., Wassmann, S., Nickenig, G., and Wassmann, K. (2011). Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese super-oxide dismutase. Basic Res. Cardiol. 106, 563-575.
96. Sobrino, A. (2011). New Expression Pathways Regulated by Estradiol in Human Endothelial Cells. Doctoral Thesis. University of Valencia.
97. Sobrino, A., Mata, M., Laguna-Fernandez, A., Novella, S., Oviedo, P. J., Garcia-Perez, M. A., Tarin, J. J., Cano, A., and Hermenegildo, C. (2009). Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS ONE 4, e8242. doi:10.1371/journal.pone.0008242
98. Sobrino, A., Oviedo, P. J., Novella, S., Laguna-Fernandez, A., Bueno, C., Garcia-Perez, M. A., Tarin, J. J., Cano, A., and Hermenegildo, C. (2010). Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. J. Mol. Endocrinol. 44, 237-246.
99. Soloff, M. S., and Szego, C. M. (1969). Purification of estradiol receptor from rat uterus and blockade of its estrogen-binding function by specific antibody. Biochem. Biophys. Res. Commun. 34, 141-147.
100. Stice, J. P., Eiserich, J. P., and Knowlton, A. A. (2009). Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 150, 212-219.
101. Sumi, D., and Ignarro, L. J. (2003). Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression. Proc. Natl. Acad. Sci. U.S.A. 100, 14451-14456.
102. Sumino, H., Ichikawa, S., Kasama, S., Kumakura, H., Takayama, Y., Sakamaki, T., and Kurabayashi, M. (2005). Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Hypertens. Res. 28, 579-584.
103. Sumino, H., Ichikawa, S., Kasama, S., Takahashi, T., Kumakura, H., Takayama, Y., Kanda, T., and Kurabayashi, M. (2006). Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 189,436-442.
104. Surra, J. C., Guillen, N., Arbones-Mainar, J. M., Barranquero, C., Navarro, M. A., Arnal, C., Orman, I., Segovia, J. C., and Osada, J. (2010). Sex as a profound modifier of atherosclerotic lesion development in apolipopro-tein E-deficient mice with different genetic backgrounds. J. Atheroscler. Thromb. 17,712-721.
105. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., and Salvetti, A. (1997). Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 29, 274-279.
106. Taddei, S., Virdis, A., Ghiadoni, L., Mattei, P., Sudano, I., Bernini, G., Pinto, S., and Salvetti, A. (1996). Menopause is associated with endothelial dysfunction in women. Hypertension 28, 576-582.
107. Takada, Y., Kato, C., Kondo, S., Kore-naga, R., and Ando, J. (1997). Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem. Biophys. Res. Commun. 240, 737-741.
108. Tang, E. H., and Vanhoutte, P. M. (2008). Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol. Genomics 32,409-418.
109. Toth, B., Scholz, C., Saadat, G., Geller, A., Schulze, S., Mylonas, I., Friese, K., and Jeschke, U. (2009). Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. Acta Histochem. 111, 508-519.
110. Valverde, M. A., Rojas, P., Amigo, J., Cosmelli, D., Orio, P., Bahamonde, M. I., Mann, G. E., Vergara, C., and Latorre, R. (1999). Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285, 1929-1931.
111. Venkov, C. D., Rankin, A. B., and Vaughan, D. E. (1996). Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94, 727-733.
112. Virdis, A., Ghiadoni, L., Giannarelli, C., and Taddei, S. (2010). Endothelial dysfunction and vascular disease in later life. Maturitas 67, 20-24.
113. Wagner, A. H., Schroeter, M. R., and Hecker, M. (2001). 17beta-estradiol inhibition of NADPH oxi-dase expression in human endothelial cells. FASEBJ. 15,2121-2130.
114. Wassmann, S., Baumer, A. T., Strehlow, K., van Eickels, M., Grohe, C., Ahlbory, K., Rosen, R., Bohm, M., and Nickenig, G. (2001). Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103,435-441.
115. Wu, Z., Maric, C., Roesch, D. M., Zheng, W., Verbalis, J. G., and Sandberg, K. (2003). Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. Endocrinology 144, 3251-3261.
116. Wynne, F. L., Payne, J. A., Cain, A. E., Reckelhoff, J. F., and Khalil, R. A. (2004). Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats. Hypertension 43, 405-412.
117. Xiong, Y., Yuan, L. W., Deng, H. W., Li, Y J., and Chen, B. M. (2001). Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28, 842-847.
118. Yoon, H. J., Cho, S. W., Ahn, B. W., and Yang, S. Y. (2010). Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech. Ageing Dev. 131, 119-123.
119. Yoshida, Y I., Eda, S., and Masada, M. (2000). Alterations of tetrahydrobiopterin biosyn-thesis and pteridine levels in mouse tissues during growth and aging. Brain Dev. 22(Suppl. 1), S45-S49.
120. Zhang, F., Ram, J. L., Standley, P. R., and Sowers, J. R. (1994). 17b-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am. J. Physiol. 266, C975-C980.
121. Zhang, Y., Stewart, K. G., and Davidge, S. T. (2000). Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 36, 970-974.